Pulling SEC filings + quote and writing the call…

IBEX Ltd
Next earnings Sep 9, 2026 (after close) · consensus $0.86 EPS, $163M rev
Last earnings -0.8% on 2026-05-06
Cheap, cash-generative BPO compounding EPS via buybacks — the AI overhang is why it trades at 13.6x, and that's the debate.
Diluted EPS $2.36 · FY2025
Quality fundamentals and an attractive price line up (~86% below fair value) — the rarer case where both the business and the entry look good.
IBEX is a profitable, steadily growing customer-experience BPO trading at a distinctly undemanding valuation: 13.6x diluted EPS and 0.8x sales for a business that grew FY2025 revenue 9.8% to $558M, lifted operating income 18.2% to $46.6M, and converted it into $45.7M of operating cash flow (+27.2%). The five-year revenue arc ($443M→$558M) is consistent, net income has climbed every year to $36.9M, and ROE is a genuinely high 27.4%. Management attributes the margin improvement to mix-shift into higher-margin offshore/nearshore regions — a trend the MD&A frames as a tailwind, since cost-focused clients are actively moving work offshore where IBEX is expanding capacity.
The EPS story needs a clear eye: diluted EPS jumped 28.3% to $2.36, but roughly two-thirds of that is buyback mechanics, not operating growth — share count fell 20.8% as the company spent $78M repurchasing stock (up 261.9%). Retiring shares near 13x earnings is accretive and shareholder-friendly, but it drained cash to just $15.3M (-75.5%) and cut equity 19%, pushing liabilities/equity to 1.03x. That is a thin cash cushion for a labor-intensive, low-margin (8.3% operating, 6.6% net) operator, and it means future buybacks likely throttle back to the modest $15M 2025 authorization rather than repeating this year's pace.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jul 3, 2026, 1:21 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $443M | $493M | $523M | $509M | $558M |
| Gross profit | — | — | — | — | — |
| Operating income | $17.0M | $20.6M | $40.5M | $39.4M | $46.6M |
| Net income | $13.1M | $21.5M | $31.6M | $33.7M | $36.9M |
| Diluted EPS | $0.71 | $1.15 | $1.67 | $1.84 | $2.36 |
| Net margin | 3.0% | 4.4% | 6.0% | 6.6% | 6.6% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Item 8.01 other event disclosed; no financial results attached
Q3 FY26 quarterly report filed alongside earnings release
Q3 FY26 quarterly report filed alongside earnings release
Q2 FY26 quarterly report filed
Q2 FY26 quarterly report filed
Board/officer change (Item 5.02); leadership transition
Annual meeting vote results plus officer/director change (5.02, 5.07)
Departure/appointment of director or officer (Item 5.02)
Q1 FY26 quarterly report filed, opening fiscal 2026
Sources: SEC EDGAR (CIK 0001720420, latest 10-Q filed 2026-05-06) · EODHD · Proprietary analysis · as of 7/3/2026, 5:21:15 AM.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
Last 90 days: 0 open-market buys · 6 sales
| 2026-06-11 | Casteel Julie K Chief Sales/Marketing Officer | Sell | 3.60K @ $30.61 | $110K |
| 2026-05-28 | McGinnis Patrick Director | Sell | 1.03K @ $31.69 | $32.6K |
| 2026-05-22 | Greenwald Taylor C Chief Financial Officer | Award | 3.33K | |
| 2026-05-22 | Greenwald Taylor C Chief Financial Officer | Sell | 964.00 @ $32.02 | $30.9K |
| 2026-05-13 | Dechant Robert Thomas Chief Executive Officer | Sell | 7.80K @ $30.50 | $238K |
| 2026-05-12 | Dawson Bruce Neil Chief Sales and CS Officer | Sell | 15.3K @ $31.12 | $475K |
| 2026-05-11 | Dawson Bruce Neil Chief Sales and CS Officer | Sell | 3.13K @ $32.80 | $103K |
| 2026-03-02 | Jones John William Director | Award | 2.25K | |
| 2026-03-02 | Zhuang Mingzhe Director | Award | 2.08K | |
| 2025-12-02 | Ballou-Aares Daniella Director | Sell | 500.00 @ $35.01 | $17.5K |
| 2025-03-13 | Ballou-Aares Daniella Director | Sell | 5.84K @ $24.22 | $142K |
| 2025-03-13 | Ballou-Aares Daniella Director | Sell | 157.00 @ $24.21 | $3.80K |
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
1195 tracked peers · median